Literature DB >> 18835022

Colon resection for ovarian cancer: intraoperative decisions.

Mitchel S Hoffman1, Emmanuel Zervose.   

Abstract

To discuss the benefits and morbidity of and indications for colon resection during cytoreductive operations for ovarian cancer. The history of cytoreductive surgery for ovarian cancer is discussed, with special attention to the incorporation of colon resection. Literature regarding cytoreductive surgery for ovarian cancer is then reviewed, again with attention to the role of colon resection. The focus of the review is directed at broad technical considerations and rationales, for both primary and secondary cytoreduction. Over the past 15 to 20 years the standard cytoreductive operation for ovarian cancer has shifted from an abdominal hysterectomy with bilateral salpingo-oophorectomy and omentectomy to an en bloc radical resection of the pelvic tumor and an omentectomy, and more recently to include increasing use of extensive upper abdominal surgery. En bloc pelvic resection frequently includes rectosigmoid resection, almost always accompanied by a primary anastomosis. Other portions of the colon are at risk for metastatic involvement and sometimes require resection in order to achieve optimal cytoreduction. The data regarding colon resection for the purpose of surgical cytoreduction of ovarian cancer are conflicting (in terms of benefit) and all retrospective. However, the preponderance of information supports a benefit in terms of survival when cytoreduction is clearly optimal. Similar to primary surgery, benefit from secondary cytoreduction of ovarian cancer occurs when only a small volume of disease is left behind. The preponderance of data suggests that colon resection to achieve optimal cytoreduction has a positive impact on survival. In order to better understand the role of colon resection as well as other extensive cytoreductive procedures for ovarian cancer, it will be important to continue to improve our understanding of prognostic variables such as the nuances of metastatic bowel involvement in order to better guide appropriate surgical management.

Entities:  

Mesh:

Year:  2008        PMID: 18835022     DOI: 10.1016/j.ygyno.2008.07.055

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Radical surgery in ovarian cancer.

Authors:  Deepa Maheswari Narasimhulu; Fady Khoury-Collado; Dennis S Chi
Journal:  Curr Oncol Rep       Date:  2015-04       Impact factor: 5.075

Review 2.  Extrapelvic bowel resection and anastomosis in cytoreductive surgery for ovarian cancer.

Authors:  Joo-Hyuk Son; Suk-Joon Chang
Journal:  Gland Surg       Date:  2021-03

3.  Subtotal Colectomy as Part of Debulking Surgery for Advanced-stage Ovarian Cancer.

Authors:  Nicolae Bacalbasa; Camelia Diaconu; Laura Iliescu; Simona Dima; Ovidiu Gabriel Bratu; Dragos Cretoiu; Adrian Neacsu; Alexandru Filipescu; Cornel Savu; Irina Balescu
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

4.  Postoperative Intestinal Fistula in Primary Advanced Ovarian Cancer Surgery.

Authors:  Antoni Llueca; Anna Serra; Maria Teresa Climent; Karina Maiocchi; Alvaro Villarin; Katty Delgado; Josep Mari-Alexandre; Juan Gilabert-Estelles; Paula Carrasco; Blanca Segarra; Luis Gomez; Juan Jose Hidalgo; Javier Escrig; Manuel Laguna
Journal:  Cancer Manag Res       Date:  2021-01-06       Impact factor: 3.989

5.  Depth of colorectal-wall invasion and lymph-node involvement as major outcome factors influencing surgical strategy in patients with advanced and recurrent ovarian cancer with diffuse peritoneal metastases.

Authors:  Angelo Di Giorgio; Maurizio Cardi; Daniele Biacchi; Simone Sibio; Fabio Accarpio; Antonio Ciardi; Tommaso Cornali; Marialuisa Framarino; Paolo Sammartino
Journal:  World J Surg Oncol       Date:  2013-03-09       Impact factor: 2.754

6.  En bloc pelvic resection for advanced ovarian cancer preceded by central ligation of vessels supplying the tumor bed: a description of surgical technique and a feasibility study.

Authors:  Jacek Jan Sznurkowski
Journal:  World J Surg Oncol       Date:  2016-04-29       Impact factor: 2.754

7.  Retroileal colorectal anastomosis after left-sided or transverse colectomy for advanced serous carcinoma of the ovary or uterus.

Authors:  Lea A Moukarzel; Joao Casanova; José Filipe Cunha; Philip B Paty; Emmanouil P Pappou; Elizabeth Jewell; Dennis S Chi
Journal:  Gynecol Oncol Rep       Date:  2021-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.